• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗痛风相关高尿酸血症的植物化学化合物:一项系统评价

Phytochemical compounds for treating hyperuricemia associated with gout: a systematic review.

作者信息

Chenchula Santenna, Ghanta Mohan Krishna, Alhammadi Munirah, Mohammed Arifullah, Anitha Kuttiappan, Nuthalapati Poojith, Raju Ganji Seeta Rama, Huh Yun Suk, Bhaskar Lvks

机构信息

Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.

Department of Pharmacology, MVJ Medical College and Research Hospital, Bangalore, 562114, Karnataka, India.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4779-4801. doi: 10.1007/s00210-024-03686-4. Epub 2024 Dec 5.

DOI:10.1007/s00210-024-03686-4
PMID:39636406
Abstract

Gout is a prevalent metabolic disorder characterized by increased uric acid (UA) synthesis or decreased UA clearance from the bloodstream, leading to the formation of urate crystals in joints and surrounding tissues. Hyperuricemia (HUA), the underlying cause of gout, poses a growing challenge for healthcare systems in developed and developing countries. Currently, the most common therapeutic approaches for gouty HUA primarily involve the use of allopathic or modern medicine. However, these treatments are often accompanied by adverse effects and may not be universally effective for all patients. Therefore, this systematic review aims to provide a comprehensive outline of phytochemical compounds that have emerged as alternative treatments for HUA associated with gout and to examine their specific mechanisms of action. A systematic search was conducted to identify phytochemicals that have previously been evaluated for their effectiveness in reducing HUA. From a review of > 800 published articles, 100 studies reporting on 50 phytochemicals associated with the management of HUA and gout were selected for analysis. Experimental models were used to investigate the effects of these phytochemicals, many of which exhibited multiple mechanisms beneficial for managing HUA. This review offers valuable insights for identifying and developing novel compounds that are safer and more effective for treating HUA associated with gout.

摘要

痛风是一种常见的代谢紊乱疾病,其特征是尿酸(UA)合成增加或血液中UA清除减少,导致关节及周围组织中尿酸盐晶体形成。高尿酸血症(HUA)是痛风的根本原因,对发达国家和发展中国家的医疗系统构成了日益严峻的挑战。目前,痛风性HUA最常见的治疗方法主要涉及使用对抗疗法或现代医学。然而,这些治疗方法往往伴有不良反应,而且可能并非对所有患者都普遍有效。因此,本系统评价旨在全面概述已成为与痛风相关的HUA替代治疗方法的植物化学化合物,并研究其具体作用机制。进行了系统检索,以确定先前已评估其降低HUA有效性的植物化学物质。通过对800多篇已发表文章的回顾,选择了100项报告50种与HUA和痛风管理相关的植物化学物质的研究进行分析。使用实验模型研究这些植物化学物质的作用,其中许多植物化学物质表现出多种有利于管理HUA的机制。本综述为识别和开发对治疗与痛风相关的HUA更安全、更有效的新型化合物提供了有价值的见解。

相似文献

1
Phytochemical compounds for treating hyperuricemia associated with gout: a systematic review.用于治疗痛风相关高尿酸血症的植物化学化合物:一项系统评价
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):4779-4801. doi: 10.1007/s00210-024-03686-4. Epub 2024 Dec 5.
2
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.别嘌醇过敏反应:1950 年至 2012 年所有已发表病例的系统回顾。
Drug Saf. 2013 Oct;36(10):953-80. doi: 10.1007/s40264-013-0084-0.
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Febuxostat for treating chronic gout.非布司他用于治疗慢性痛风。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD008653. doi: 10.1002/14651858.CD008653.pub2.
5
Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.慢性肾脏病患者痛风性关节炎管理面临的挑战:系统评价。
Semin Arthritis Rheum. 2012 Oct;42(2):166-78. doi: 10.1016/j.semarthrit.2012.03.013. Epub 2012 May 3.
6
Interventions for tophi in gout.痛风石的治疗。
Cochrane Database Syst Rev. 2021 Aug 11;8(8):CD010069. doi: 10.1002/14651858.CD010069.pub3.
7
Influence of Gut Microbiota-Derived Butyrate on Intestinal Uric Acid Excretion and Hyperuricemia Regulation by L.肠道微生物群衍生的丁酸盐对肠道尿酸排泄及L.对高尿酸血症调节的影响
Int J Mol Sci. 2025 Jul 3;26(13):6413. doi: 10.3390/ijms26136413.
8
Efficacy and safety of urate-lowering treatments in patients with hyperuricemia: A comprehensive network meta-analysis of randomized controlled trials.降尿酸治疗对高尿酸血症患者的疗效和安全性:一项随机对照试验的综合网络荟萃分析。
J Clin Pharm Ther. 2020 Aug;45(4):729-742. doi: 10.1111/jcpt.13156. Epub 2020 May 13.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.

本文引用的文献

1
Evaluation of anti-hyperuricemic effects of Miq. (Keladi Candik) extracts in potassium oxonate induced rat model.米克(Keladi Candik)提取物对氧嗪酸钾诱导的大鼠模型抗高尿酸血症作用的评估。
Heliyon. 2023 Jul 7;9(7):e18069. doi: 10.1016/j.heliyon.2023.e18069. eCollection 2023 Jul.
2
Magnetic resonance imaging and ultrasound elastography in the context of preclinical pharmacological research: significance for the 3R principles.临床前药理研究背景下的磁共振成像和超声弹性成像:对3R原则的意义
Front Pharmacol. 2023 Jun 28;14:1177421. doi: 10.3389/fphar.2023.1177421. eCollection 2023.
3
Antioxidant and Anti-inflammatory Effects of α-Lipoic Acid on Lipopolysaccharide-induced Oxidative Stress in Rat Kidney.
α-硫辛酸对脂多糖诱导的大鼠肾氧化应激的抗氧化和抗炎作用。
Arch Immunol Ther Exp (Warsz). 2023 Jun 28;71(1):16. doi: 10.1007/s00005-023-00682-z.
4
Research progress on the prevention and treatment of hyperuricemia by medicinal and edible plants and its bioactive components.药食两用植物及其生物活性成分防治高尿酸血症的研究进展
Front Nutr. 2023 Jun 12;10:1186161. doi: 10.3389/fnut.2023.1186161. eCollection 2023.
5
Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout.基于网络药理学和肠道微生物组学分析揭示祛浊通痹方治疗高尿酸血症和痛风的作用机制。
J Ethnopharmacol. 2023 Nov 15;316:116736. doi: 10.1016/j.jep.2023.116736. Epub 2023 Jun 5.
6
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota.黄连素通过抑制肠道微生物群中肠道源性尿毒症毒素的产生来改善慢性肾脏病。
Acta Pharm Sin B. 2023 Apr;13(4):1537-1553. doi: 10.1016/j.apsb.2022.12.010. Epub 2022 Dec 20.
7
In-vitro antigout potential of flower, characterization and prospective ligand-receptor interaction of bioactive lead compound.花的体外抗痛风潜力、生物活性先导化合物的表征及潜在配体-受体相互作用
Heliyon. 2023 Feb 28;9(3):e14093. doi: 10.1016/j.heliyon.2023.e14093. eCollection 2023 Mar.
8
Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation.基于网络药理学和体内证据的五苓散抗高尿酸血症作用:改善氧化应激和抑制炎症。
Drug Des Devel Ther. 2023 Mar 4;17:675-690. doi: 10.2147/DDDT.S398625. eCollection 2023.
9
Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System.黄柏抗炎作用机制研究——基于小檗碱载红细胞自组装靶向递药系统
Drug Des Devel Ther. 2022 Dec 23;16:4365-4383. doi: 10.2147/DDDT.S385301. eCollection 2022.
10
Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics.葫芦素B:药理学、毒性及药代动力学综述
Pharmacol Res. 2023 Jan;187:106587. doi: 10.1016/j.phrs.2022.106587. Epub 2022 Nov 30.